Literature DB >> 15987679

The MUC1 SEA module is a self-cleaving domain.

Fiana Levitin1, Omer Stern, Mordechai Weiss, Chava Gil-Henn, Ravit Ziv, Zofnat Prokocimer, Nechama I Smorodinsky, Daniel B Rubinstein, Daniel H Wreschner.   

Abstract

MUC1, a glycoprotein overexpressed by a variety of human adenocarcinomas, is a type I transmembrane protein (MUC1/TM) that soon after its synthesis undergoes proteolytic cleavage in its extracellular domain. This cleavage generates two subunits, alpha and beta, that specifically recognize each other and bind together in a strong noncovalent interaction. Proteolysis occurs within the SEA module, a 120-amino acid domain that is highly conserved in a number of heavily glycosylated mucin-like proteins. Post-translational cleavage of the SEA module occurs at a site similar to that in MUC1 in the glycoproteins IgHepta and MUC3. However, as in the case of other proteins containing the cleaved SEA module, the mechanism of MUC1 proteolysis has not been elucidated. Alternative splicing generates two transmembrane MUC1 isoforms, designated MUC1/Y and MUC1/X. We demonstrated here that MUC1/X, whose extracellular domain is comprised solely of the SEA module in addition to 30 MUC1 N-terminal amino acids, undergoes proteolytic cleavage at the same site as the MUC1/TM protein. In contrast, the MUC1/Y isoform, composed of an N-terminally truncated SEA module, is not cleaved. Cysteine or threonine mutations of the MUC1/X serine residue (Ser-63) immediately C-terminal to the cleavage site generated cleaved proteins, whereas mutation of the Ser-63 residue of MUC1/X to any other of 17 amino acids did not result in cleavage. In vitro incubation of highly purified precursor MUC1/X protein resulted in self-cleavage. Furthermore, addition of hydroxylamine, a strong nucleophile, markedly enhanced cleavage. Both these features are signature characteristics of self-cleaving proteins, and we concluded that MUC1 undergoes autoproteolysis mediated by an N --> O-acyl rearrangement at the cleavage site followed by hydrolytic resolution of the unstable ester and concomitant cleavage. It is likely that all cleaved SEA module-containing proteins follow a similar route.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987679     DOI: 10.1074/jbc.M506047200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

1.  MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling.

Authors:  Jian Ren; Deepak Raina; Wen Chen; Guilan Li; Lei Huang; Donald Kufe
Journal:  Mol Cancer Res       Date:  2006-11       Impact factor: 5.852

2.  O-glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model.

Authors:  Pushpa Premaratne; Karin Welén; Jan-Erik Damber; Gunnar C Hansson; Malin Bäckström
Journal:  Tumour Biol       Date:  2010-09-26

Review 3.  Lewis x is highly expressed in normal tissues: a comparative immunohistochemical study and literature revision.

Authors:  María V Croce; Marina Isla-Larrain; Martín E Rabassa; Sandra Demichelis; Andrea G Colussi; Marina Crespo; Ezequiel Lacunza; Amada Segal-Eiras
Journal:  Pathol Oncol Res       Date:  2007-07-03       Impact factor: 3.201

4.  Physical biology of the cancer cell glycocalyx.

Authors:  Joe Chin-Hun Kuo; Jay G Gandhi; Roseanna N Zia; Matthew J Paszek
Journal:  Nat Phys       Date:  2018-07-04       Impact factor: 20.034

Review 5.  Post-translational regulation of signaling mucins.

Authors:  Paul J Cullen
Journal:  Curr Opin Struct Biol       Date:  2011-08-31       Impact factor: 6.809

6.  PATE gene clusters code for multiple, secreted TFP/Ly-6/uPAR proteins that are expressed in reproductive and neuron-rich tissues and possess neuromodulatory activity.

Authors:  Fiana Levitin; Mordechai Weiss; Yoonsoo Hahn; Omer Stern; Roger L Papke; Robert Matusik; Srinivas R Nandana; Ravit Ziv; Edward Pichinuk; Sharbel Salame; Tapan Bera; James Vincent; Byungkook Lee; Ira Pastan; Daniel H Wreschner
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

7.  MUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8.

Authors:  Naoki Agata; Rehan Ahmad; Takeshi Kawano; Deepak Raina; Surender Kharbanda; Donald Kufe
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

8.  Orphan receptor GPR110, an oncogene overexpressed in lung and prostate cancer.

Authors:  Amy M Lum; Bruce B Wang; Gabriele B Beck-Engeser; Lauri Li; Namitha Channa; Matthias Wabl
Journal:  BMC Cancer       Date:  2010-02-11       Impact factor: 4.430

9.  Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.

Authors:  Arivalagan Muthusamy; Carlton R Cooper; Ronald R Gomes
Journal:  BMC Biochem       Date:  2010-11-03       Impact factor: 4.059

10.  Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancer.

Authors:  Mark D Pegram; Virginia F Borges; Nuhad Ibrahim; Jyotsna Fuloria; Charles Shapiro; Susan Perez; Karen Wang; Franziska Schaedli Stark; Nigel Courtenay Luck
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.